THE MUSCULOSKELETAL SYNDROME OF MENOPAUSE

Menopause care has
a musculoskeletal
blind spot.

Menopause
care has a musculoskeletal
blind spot.

Menopause care has a musculoskeletal blind spot.

I know because I fell through it.

70%+

Of women experience musculoskeletal symptoms during menopause

40%

will have no structural findings on imaging

25%

Are estimated to be disabled by them

What is the musculoskeletal syndrome of menopause?

The musculoskeletal syndrome of menopause is a term introduced by orthopedic surgeon Dr. Wright and colleagues to describe a debilitating cluster of midlife musculoskeletal symptoms associated with the decline in estrogen across the menopause transition. Estrogen has structural effects throughout the musculoskeletal system.

Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024;27(5):466–472.

Read the Study

Arthralgia

widespread joint and muscle pain

Sarcopenia

loss of lean muscle mass and strength

Bone density loss

osteopenia, osteoporosis, and increased fracture risk

Frozen shoulder & osteoarthritis

adhesive capsulitis and progression of osteoarthritis

Tendon & ligament injury

reduced joint stability and increased soft tissue injury

Connective tissue changes

connective tissue matrix changes and cartilage matrix fragility

I know what the 25% looks like

I spent my career helping organizations recognize risks they’d missed. This time, I was the consequence of one.

During the menopause transition, my disabling symptoms accelerated. My underlying connective-tissue disorder wasn’t diagnosed until I was facing Chiari decompression and occipital-to-C3 fusion at 50.

No clinician has established menopause as the cause in my case. But the timing, and emerging science on estrogen and connective tissue, is why I believe this gap deserves attention.

The Guidance Gap

On naming the musculoskeletal
syndrome of menopause

“It’s important to give the problem a name, so we can really talk about it, study it, and pay attention to it.”

DEBORAH GOMEZ KWOLEK, MD · HARVARD

MEDICAL SCHOOL & MASS GENERAL BRIGHAM

As quoted in Harvard Health Publishing, June 2026.

The musculoskeletal effects of menopause are recognized. The syndrome that connects them is not yet routinely named in menopause care.

Advocacy

Closing the gap in Massachusetts

I'm working with Massachusetts legislators and clinicians to close gaps in menopause care, including how the musculoskeletal syndrome of menopause can be recognized in state policy.

Advocacy

Closing the gap in Massachusetts

I'm working with Massachusetts legislators and clinicians to close gaps in menopause care, including how the musculoskeletal syndrome of menopause can be recognized in state policy.

Advocacy

Closing the gap in Massachusetts

I'm working with Massachusetts legislators and clinicians to close gaps in menopause care, including how the musculoskeletal syndrome of menopause can be recognized in state policy.

"Menopause can convert compensated

joint hypermobility or connective tissue

disorders into symptomatic disease."

"Menopause can convert compensated

joint hypermobility or connective tissue

disorders into symptomatic disease."

Dr. Linda Bluestein, hypermobility specialist

Hormones, Menopause and Connective Tissue Disorders, Ehlers-Danlos Support UK, May 8, 2026 (1:24:28).

The full webinar is in my curated resource library.

Watch the Webinar

Please note: The information provided here is for general reference only and does not constitute medical advice, diagnosis, or treatment. It includes descriptions of personal experience, which are not a substitute for professional care. Always consult a qualified healthcare professional with any questions or concerns about your health.